(Q38178536)

30 August 2017

title

Colchicine for secondary prevention of cardiovascular disease (English)

1 reference

30 August 2017

1 reference

2

John W Eikelboom

1 reference

30 August 2017

Stefan M Nidorf

1

1 reference

30 August 2017

Peter L Thompson

series ordinal

3

1 reference

30 August 2017

publication date

1 March 2014

1 reference

Current Atherosclerosis Reports

30 August 2017

published in

1 reference

30 August 2017

volume

16

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

391

1 reference

Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

A prospective natural-history study of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Multiple roles for neutrophils in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Mechanisms of acute coronary syndromes and their implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Use of oral corticosteroids and the risk of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Effects of low-dose aspirin on acute inflammatory responses in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events--a novel insight into plaque rupture by scanning electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Cholesterol crystals and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

A controlled trial of colchicine in preventing attacks of familial mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

History of the use of colchicum and related medicaments in gout; with suggestions for further research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Low-dose colchicine for secondary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Update on colchicine and its mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Characterization of cholesterol crystals in atherosclerotic plaques using stimulated Raman scattering and second-harmonic generation microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Intraplaque haemorrhages as the trigger of plaque vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Crystal-induced endogenous pyrogen production. A further look at gouty inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Coronary Plaque Disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Effect of colchicine on rat mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

The inhibitory effects of colchicine on cell proliferation and mineralisation in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

The pathogenesis of bone erosions in gouty arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Oral colchicine (Colcrys): in the treatment and prophylaxis of gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Colchicine is a safe drug in children with familial Mediterranean fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Pregnancy outcome after in utero exposure to colchicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Azoospermia in familial Mediterranean fever patients: the role of colchicine and amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Acute myopathy in a patient with concomitant use of pravastatin and colchicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Colchicine for pericarditis: hype or hope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Canakinumab induces remission in a patient with resistant familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Foam cells of the rabbit atherosclerotic plaque arrested in metaphase by colchicine show a macrophage phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0391-Z

Prevalence of ischemic heart disease in patients with familial Mediterranean fever.

21 January 2018

1 reference

12 December 2020

Colchicine in clinical medicine. A guide for internists.

1 reference

12 December 2020

Cell proliferation in the atherosclerotic plaques of cholesterol-fed rabbits. 1. Colchicine and (3H)thymidine studies

1 reference

12 December 2020

Colchicine use for familial Mediterranean fever. Observations associated with long-term treatment.

1 reference

12 December 2020

Mechanisms for the anti-inflammatory effects of statins

1 reference

12 December 2020

Neutrophil infiltration of culprit lesions in acute coronary syndromes

1 reference

12 December 2020

Regression of nephrotic syndrome due to amyloidosis secondary to familial mediterranean fever following colchicine treatment

1 reference

12 December 2020

1 reference

12 December 2020

Parallel cholesterol crystals: a sign of impending plaque rupture?

1 reference

12 December 2020

Medullary aplasia after acute colchicine poisoning. 20 cases

1 reference

12 December 2020

The effect of colchicine on the development of experimental atherosclerosis in rabbits

1 reference

12 December 2020

Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization

1 reference

12 December 2020

Modification of cholesterol crystal-induced inflammation

1 reference

12 December 2020

Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis

1 reference

12 December 2020

Colchicine disposition in human leukocytes after single and multiple oral administration

1 reference

12 December 2020

The experimental production of arteriosclerosis: response of the avian artery to intramural cholesterol and other insoluble substances.

1 reference

12 December 2020

Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation.

1 reference

12 December 2020

Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients

1 reference

12 December 2020

THE EFFECT OF PRETREATMENT WITH COLCHICINE ON THE INFLAMMATORY RESPONSE TO MICROCRYSTALLINE URATE: A MODEL FOR GOUTY INFLAMMATION

1 reference

12 December 2020

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

1 reference

12 December 2020

Colchicine-induced myopathy and neuropathy

1 reference

12 December 2020

Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation

1 reference

12 December 2020

Are dosing adjustments required for colchicine in the elderly compared with younger patients?

1 reference

12 December 2020

Colchicine antagonizes the activity of human smooth muscle cells cultivated from arteriosclerotic lesions after atherectomy

1 reference

12 December 2020

Colchicine-induced leukopenia in a patient with familial Mediterranean fever: the cause and a possible approach.

1 reference

12 December 2020

Metabolic and morphologic effects of colchicine on human T-lymphocyte expression of Fcμ, and Fcγ receptors

1 reference

12 December 2020

Growth-inhibiting effect of colchicine on cultured vascular wall myocytes from arteriosclerotic lesions

1 reference

12 December 2020

Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008

1 reference

12 December 2020

10.1007/S11883-013-0391-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1010048430

0 references

1 reference